Article

Investigation of the association of serum GFAP and NfL with brain and upper cervical MRI volumes in AQP4-IgG-positive NMOSD and MOGAD.
Schindler, Patrick ORCID: https://orcid.org/0000-0002-8846-121X, Grittner, Ulrike, Rust, Rebekka, Asseyer, Susanna, Bellmann-Strobl, Judith ORCID: https://orcid.org/0000-0003-2615-1643, Schmitz-Hübsch, Tanja ORCID: https://orcid.org/0000-0003-4833-5937, Scheel, Michael, Jarius, Sven, Wildemann, Brigitte, Reindl, Markus ORCID: https://orcid.org/0000-0003-2817-1402, Benkert, Pascal, Kuhle, Jens, Paul, Friedemann ORCID: https://orcid.org/0000-0002-6378-0070, Ruprecht, Klemens and Chien, Claudia ORCID: https://orcid.org/0000-0001-8280-9513
Therapeutic Advances in Neurological Disorders 18 : 17562864251345792. 2025

Treatment switches of disease-modifying therapies in people with multiple sclerosis: long-term experience from the German MS Registry.
Frahm, N. ORCID: https://orcid.org/0000-0002-4655-774X, Ellenberger, D., Stahmann, A., Fneish, F., Lüftenegger, D., Salmen, H.C., Schirduan, K. ORCID: https://orcid.org/0009-0004-0666-7444, Schaak, T.P.A., Flachenecker, P., Kleinschnitz, C., Paul, F. ORCID: https://orcid.org/0000-0002-6378-0070, Krefting, D., Zettl, U.K., Peters, M. and Warnke, C.
Therapeutic Advances in Neurological Disorders 17 : 17562864241239740. 2024

Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohort.
Salmen, A. ORCID: https://orcid.org/0000-0002-4751-299X, Hoepner, R. ORCID: https://orcid.org/0000-0002-0115-7021, Fleischer, V. ORCID: https://orcid.org/0000-0002-3293-5121, Heldt, M., Gisevius, B., Motte, J. ORCID: https://orcid.org/0000-0002-6624-8565, Ruprecht, K., Schneider, R., Fisse, A.L. ORCID: https://orcid.org/0000-0003-0493-8656, Grüter, T., Lukas, C., Berthele, A., Giglhuber, K., Flaskamp, M., Mühlau, M., Kirschke, J., Bittner, S., Groppa, S., Lüssi, F. ORCID: https://orcid.org/0000-0003-4334-4199, Bayas, A., Meuth, S., Heesen, C. ORCID: https://orcid.org/0000-0001-8131-9467, Trebst, C., Wildemann, B., Then Bergh, F., Antony, G., Kümpfel, T., Paul, F. ORCID: https://orcid.org/0000-0002-6378-0070, Nischwitz, S., Tumani, H. ORCID: https://orcid.org/0000-0002-1647-6201, Zettl, U., Hemmer, B. ORCID: https://orcid.org/0000-0001-5985-6784, Wiendl, H. ORCID: https://orcid.org/0000-0003-4310-3432, Zipp, F. and Gold, R. ORCID: https://orcid.org/0000-0002-7223-3052
Therapeutic Advances in Neurological Disorders 16 : 17562864231197309. 8 September 2023

Mepolizumab as an effective treatment in a case of hypophysitis in eosinophilic granulomatosis with polyangiitis.
Chen, J. ORCID: https://orcid.org/0000-0002-4355-4121, Alexander, T., Walter-Rittel, T., Ziagaki, A. and Siffrin, V. ORCID: https://orcid.org/0000-0002-1532-2868
Therapeutic Advances in Neurological Disorders 16 : 17562864231182519. 2023

Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany.
Stroet, A., Hemmelmann, C., Starck, M., Zettl, U., Doerr, J., Paul, F. ORCID: https://orcid.org/0000-0002-6378-0070, Flachenecker, P., Fleischer, V., Zipp, F. ORCID: https://orcid.org/0000-0002-1231-1928, Nueckel, H., Kieseier, B.C., Ziegler, A., Gold, R. and Chan, A.
Therapeutic Advances in Neurological Disorders 5 (2): 75-79. March 2012

Review

Brain volumetry and spinal cord imaging in patients with AQP4-IgG+ NMOSD - a systematic review and meta-analysis.
Heine, Josephine ORCID: https://orcid.org/0000-0001-5226-6650 and Chien, Claudia ORCID: https://orcid.org/0000-0001-8280-9513
Therapeutic Advances in Neurological Disorders 18 : 1-22. December 2025

A window into the future? MRI for evaluation of neuromyelitis optica spectrum disorder throughout the disease course.
Solomon, J.M., Paul, F. ORCID: https://orcid.org/0000-0002-6378-0070, Chien, C. ORCID: https://orcid.org/0000-0001-8280-9513, Oh, J. ORCID: https://orcid.org/0000-0001-5519-6088 and Rotstein, D.L. ORCID: https://orcid.org/0000-0002-7280-3684
Therapeutic Advances in Neurological Disorders 14 : 175628642110143. 9 May 2021

Bevacizumab in temozolomide refractory high-grade gliomas: single-centre experience and review of the literature.
Jeck, J., Kassubek, R., Coburger, J., Edenhofer, S., Schönsteiner, S.S., Ludolph, A.C., Schmitz, B., Engelke, J., Mayer-Steinacker, R., Lewerenz, J. and Bullinger, L. ORCID: https://orcid.org/0000-0002-5890-5510
Therapeutic Advances in Neurological Disorders 11 : 1756285617753597. 21 January 2018